We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Theravance Biopharma Inc | NASDAQ:TBPH | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.40 | 4.74% | 8.84 | 8.50 | 9.97 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 8.98 | 8.40 | 8.44 | 2,056,947 | 22:53:17 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 09/5/2023 | 23:58 | DJN | Theravance Says FDA Grants Orphan Drug Designation Status to Ampreloxetine |
1 Year Theravance Biopharma Chart |
Intraday Theravance Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
